drugset / Trial / NCT04334213

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150

NCT04334213

Phase 1 Completed 48 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A Clinical trial to investigate the pharmacokinetic drug interaction and safety of CKD-501, D745 and D150

Timeline

Start
2020-05-07
Primary completion
2020-08-05
Completion
2020-08-05

Drugs

EvaluationDrugModalityDoseRoute
Subject D150 Unknown Oral
Subject D745 Unknown Oral
Subject Lobeglitazone Small molecule Oral